Łukasz Białek

MD PhD | Urologist in training | Reconstructive urology | Bladder cancer | @EAU_YAURecon Associate Member

[EAU YAU: Trauma & Reconstructive Urology @EAU_YAURecon]

We happily introduce the stricture-fecta, a Delphi consensus-based framework for standardized outcome reporting in urethral reconstruction.
https://t.co/3P1G1KgpQY We deeply appreciate the contribution of the international Stricture-fecta Delphi Consensus Panel!

[Celeste Manfredi @ManfrediCeleste]

🆕 Just released by @Clarivate : the #JournalCitationReports2025!

Here’s the full list 📃 of all journals in #Urology and #Andrology, ranked by 2024 #ImpactFactors.

A practical tool to choose where to publish your next paper!

👇 Save & share it with colleagues!

[EAU YAU: Trauma & Reconstructive Urology @EAU_YAURecon]

We’ve summarized evidence from the ROBUST trials on #Optilume to highlight when paclitaxel-coated balloon dilation for #urethralstricture works, needs caution, or should be avoided. Read more: https://t.co/HlCJ3ddvEQ @EurUrolFocus @Uroweb @EAUYAUrology

[M.Frankiewicz @frankiewicz_mi]

🚀 Excited to unveil the "SAFER" project by the @EAU_YAURecon, tackling AUS erosion with cutting-edge research! Our goal? To standardize care with evidence-based strategies. @EAUYAUrology @mwvetterlein @Uroweb @ManticaGu
@GUMedGdansk

[Pawel Rajwa @dr_rajwa]

Can we effectively prevent PCa progression during AS in 2023? Read our SR and MA! @DrShariat @philcornford @GPloussard @veerukasi @JGomezRivas @BenjaminPradere @GGandaglia @EurUrolOncol https://t.co/mO2Y2cECq9

[Tom Powles @tompowles1]

Enfortumab vedotin & Pembrolizumab improving PFS & OS by 55% & 53% respectively compared to platinum based chemo in 1st line UC (+avelumab in 30%). Chemo has not been beaten before (despite multiple efforts). RR and CR of 68% & 29% is hard to beat. DOR not reached (1/3)#ESMO2023

[Łukasz Białek @lukaszbtm]

Should we routinely use antibiotics after urethral reconstruction? Probably not, but good quality scientific evidence is lacking. Check out more in our newly published SR! https://t.co/VanLaLtcEc
@EAU_YAURecon @mwvetterlein

[Łukasz Białek @lukaszbtm]

I'm extremely honored and happy to become an Associate Member of @EAU_YAURecon! Thank you for your trust and can't wait to work with you on the scientific projects! @EAUYAUrology @mwvetterlein @frankiewicz_mi @PTUweb

[Łukasz Białek @lukaszbtm]

@drtomrynkiewicz @PTUweb Ja jestem, do zobaczenia! ;)

[Bartosz Dybowski @BDybowski]

ReTURBT in our dept:
residual d. 40% (HG only predictor)
Upstage 7%
https://t.co/R0ALK9hp2F
@SPoletajew @ZapalaPiotr
@RadziszewskiPi